Our findings indicated that silencing circGDI2 inhibited HCC cell proliferation and glycolysis and suppressed PKM2 level, and this inhibitory effect was mediated by IGF2BP2. The gene discussed is IGF2BP2; the disease is hepatocellular carcinoma.